ReviewCurrent oncology (Toronto, Ont.)2026
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers.
Giusi Bondì et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.